LAX.SH
PAR DRUGS AND CHEM LTD·Healthcare Companies·Pharmaceuticals & Biotechnology Companies
Price
104.6
-0.4%52W Range
Market Cap
₹128.71 Cr
Traded: ₹0.12 Cr (0.09%) 0.0x
Free Float: ₹31.80 Cr (0.37% of FF traded)
Volume · 60D trend
11.38 K 0.0x
Delivery: % 0.0x
View Delivery Data
Returns
RS Score
Create a free account to unlock your edge
Scanners, market pulse, FII/DII data, and TradingView charts — free forever
Valuation
Business Strength
Growth (3Y CAGR)
Balance Sheet
Cash Position
Others
MTF Exposure Trend
60 sessions · funded amount, % of FF, daily delta
LAX.SH
Growth Trends
| Metric | 10Y | 5Y | 3Y | 1Y | TTM | Trend |
|---|---|---|---|---|---|---|
| Sales | +12.0% | +11.0% | +3.0% | -- | +4.0% | Stable |
| Return | -- | -4.0% | -19.0% | -3.0% | -- | Stable |
| Profit | +41.0% | +5.0% | +5.0% | -- | +2.0% | Stable |
| ROE | +15.0% | +15.0% | +15.0% | -- | -- | Stable |
Quarterly Results
Revenue & Margin Trends
Annual
Quarterly
Balance Sheet Health
Leverage
Efficiency
Cash Position
Detailed Financials
Jun 2026PDF ↗ | Mar 2026PDF ↗ | Dec 2025PDF ↗ | Sep 2025PDF ↗ | Jun 2025PDF ↗ | Mar 2025PDF ↗ | Dec 2024PDF ↗ | Sep 2024PDF ↗ | Jun 2024PDF ↗ | Mar 2024PDF ↗ | Dec 2023PDF ↗ | Sep 2023PDF ↗ | Jun 2023PDF ↗ | Mar 2023PDF ↗ | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 31 | 20 | 29 | 29 | 26 | 22 | 21 | 35 | 23 | 23 | 24 | 26 | 23 | 24 |
| Expenses | 25 | 18 | 23 | 23 | 22 | 20 | 20 | 23 | 18 | 17 | 19 | 19 | 19 | 19 |
| Operating Profit | 6 | 1 | 6 | 6 | 4 | 2 | 1 | 11 | 4 | 6 | 5 | 7 | 4 | 5 |
| Other Income | 1 | 0 | 1 | 0 | 2 | 1 | 0 | 1 | 0 | -0 | 0 | 0 | 0 | 0 |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Depreciation | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| Profit Before Tax | 6 | 1 | 6 | 6 | 4 | 2 | 1 | 11 | 3 | 5 | 5 | 7 | 3 | 5 |
| Tax % | 25.6% | -3.6% | 25.5% | 25.6% | 25.7% | 27.6% | 24.4% | 25.1% | 25.1% | 27.2% | 25.2% | 25.3% | 25.1% | 24.0% |
| Net Profit | 5 | 1 | 5 | 4 | 3 | 2 | 1 | 9 | 3 | 4 | 3 | 5 | 2 | 3 |
| Exceptional Items | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| EPS (Rs) | 3.8 | 0.7 | 3.9 | 3.4 | 2.7 | 1.3 | 0.5 | 7.0 | 2.1 | 3.0 | 2.8 | 4.0 | 2.0 | 2.8 |
| Sales Growth (YoY) | 20.1% | -12.2% | 37.2% | -17.3% | 15.2% | -2.1% | -10.9% | 33.9% | -1.4% | -6.8% | -- | -- | -- | -- |
| Sales Growth (QoQ) | 59.5% | -33.2% | 2.4% | 10.0% | 16.7% | 4.4% | -38.3% | 53.3% | -0.9% | -4.9% | -7.3% | 12.9% | -6.4% | -- |
| OP Growth (YoY) | 78.9% | -40.7% | 323.1% | -46.9% | -16.0% | -60.2% | -72.7% | 55.0% | 2.4% | 13.2% | -- | -- | -- | -- |
| OP Growth (QoQ) | 342.4% | -76.2% | -0.2% | 70.2% | 46.5% | 69.9% | -87.5% | 169.1% | -30.5% | 16.6% | -28.9% | 77.8% | -23.2% | -- |
| Profit Growth (YoY) | 41.4% | -48.5% | 727.6% | -52.0% | 31.6% | -55.6% | -83.0% | 75.9% | 2.4% | 7.8% | 82.9% | 31.1% | 7.9% | 42.6% |
| EPS Growth (YoY) | 41.3% | -48.5% | 729.8% | -51.9% | 31.6% | -55.6% | -83.1% | 76.1% | 2.5% | 7.9% | -- | -- | -- | -- |
| EPS Growth (QoQ) | 455.1% | -82.3% | 16.1% | 24.0% | 102.2% | 185.1% | -93.3% | 239.3% | -31.8% | 8.6% | -30.0% | 97.5% | -28.2% | -- |
| OP Margin | 20.4% | 7.3% | 20.6% | 21.1% | 13.7% | 10.9% | 6.7% | 32.9% | 18.8% | 26.7% | 21.8% | 28.4% | 18.1% | 22.0% |
| Net Margin | 15.1% | 4.3% | 16.4% | 14.4% | 12.8% | 7.4% | 2.7% | 24.8% | 11.2% | 16.3% | 14.3% | 18.9% | 10.8% | 14.1% |
| Material Cost % | 44.0% | 45.4% | 42.2% | 37.4% | 43.5% | 43.8% | 41.2% | 34.8% | 33.1% | 31.8% | 32.7% | 34.8% | 42.2% | 36.1% |
| Employee Cost % | 5.4% | 9.9% | 4.8% | 4.7% | 5.5% | 8.6% | 6.2% | 3.9% | 5.6% | 7.8% | 6.0% | 4.5% | 4.9% | 6.4% |
| P/S | 1.18 | 1.17 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| P/E | 8.88 | 9.23 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| P/B | 1.15 | 1.08 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
Concalls
17Jun 2023
30 Jun 2023Jun 2023
30 Jun 2023Mar 2023
31 Mar 2023Mar 2023
31 Mar 2023Feb 2023
28 Feb 2023Nov 2022
30 Nov 2022Nov 2022
30 Nov 2022Aug 2022
31 Aug 2022May 2022
31 May 2022Feb 2022
28 Feb 2022Dec 2021
31 Dec 2021Nov 2021
30 Nov 2021Jun 2021
30 Jun 2021Nov 2020
30 Nov 2020Nov 2020
30 Nov 2020Jun 2020
30 Jun 2020Sep 2019
30 Sept 2019